Official reprint from UpToDate®
www.uptodate.com ©2016 UpToDate®

Gynecomastia in children and adolescents

Sharonda A Taylor, MD
Section Editors
Diane Blake, MD
Mitchell Geffner, MD
Deputy Editor
Mary M Torchia, MD


This topic will focus on the evaluation of gynecomastia in children and adolescents. Gynecomastia in adults is discussed separately:

(See "Epidemiology, pathophysiology, and causes of gynecomastia".)

(See "Clinical features, diagnosis, and evaluation of gynecomastia".)

(See "Management of gynecomastia".)


Gynecomastia is the benign proliferation of glandular breast tissue in males. It differs from proliferation of breast tissue in females in that there is no terminal alveolar development in response to progesterone [1].


Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Sep 2016. | This topic last updated: Oct 21, 2016.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2016 UpToDate, Inc.
  1. Braunstein GD. Gynecomastia. N Engl J Med 1993; 328:490.
  2. Li RZ, Xia Z, Lin HH, et al. Childhood gynecomastia: a clinical analysis of 240 cases. Zhongguo Dang Dai Er Ke Za Zhi 2007; 9:404.
  3. Kumanov P, Deepinder F, Robeva R, et al. Relationship of adolescent gynecomastia with varicocele and somatometric parameters: a cross-sectional study in 6200 healthy boys. J Adolesc Health 2007; 41:126.
  4. Rosen H, Webb ML, DiVasta AD, et al. Adolescent gynecomastia: not only an obesity issue. Ann Plast Surg 2010; 64:688.
  5. Ma NS, Geffner ME. Gynecomastia in prepubertal and pubertal men. Curr Opin Pediatr 2008; 20:465.
  6. Braunstein GD. Clinical practice. Gynecomastia. N Engl J Med 2007; 357:1229.
  7. Lee PA. The relationship of concentrations of serum hormones to pubertal gynecomastia. J Pediatr 1975; 86:212.
  8. Harlan WR, Grillo GP, Cornoni-Huntley J, Leaverton PE. Secondary sex characteristics of boys 12 to 17 years of age: the U.S. Health Examination Survey. J Pediatr 1979; 95:293.
  9. Mieritz MG, Sorensen K, Aksglaede L, et al. Elevated serum IGF-I, but unaltered sex steroid levels, in healthy boys with pubertal gynaecomastia. Clin Endocrinol (Oxf) 2014; 80:691.
  10. Mieritz MG, Rakêt LL, Hagen CP, et al. A Longitudinal Study of Growth, Sex Steroids, and IGF-1 in Boys With Physiological Gynecomastia. J Clin Endocrinol Metab 2015; 100:3752.
  11. Madlon-Kay DJ. 'Witch's milk'. Galactorrhea in the newborn. Am J Dis Child 1986; 140:252.
  12. NYDICK M, BUSTOS J, DALE JH Jr, RAWSON RW. Gynecomastia in adolescent boys. JAMA 1961; 178:449.
  13. Biro FM, Lucky AW, Huster GA, Morrison JA. Hormonal studies and physical maturation in adolescent gynecomastia. J Pediatr 1990; 116:450.
  14. Nordt CA, DiVasta AD. Gynecomastia in adolescents. Curr Opin Pediatr 2008; 20:375.
  15. Johnson RE, Murad MH. Gynecomastia: pathophysiology, evaluation, and management. Mayo Clin Proc 2009; 84:1010.
  16. Limony Y, Friger M, Hochberg Z. Pubertal gynecomastia coincides with peak height velocity. J Clin Res Pediatr Endocrinol 2013; 5:142.
  17. Mahoney CP. Adolescent gynecomastia. Differential diagnosis and management. Pediatr Clin North Am 1990; 37:1389.
  18. Sher ES, Migeon CJ, Berkovitz GD. Evaluation of boys with marked breast development at puberty. Clin Pediatr (Phila) 1998; 37:367.
  19. Marynick SP, Nisula BC, Pita JC Jr, Loriaux DL. Persistent pubertal macromastia. J Clin Endocrinol Metab 1980; 50:128.
  20. Dickson G. Gynecomastia. Am Fam Physician 2012; 85:716.
  21. Braunstein GD. Aromatase and gynecomastia. Endocr Relat Cancer 1999; 6:315.
  22. Nuttall FQ, Warrier RS, Gannon MC. Gynecomastia and drugs: a critical evaluation of the literature. Eur J Clin Pharmacol 2015; 71:569.
  23. Henley DV, Lipson N, Korach KS, Bloch CA. Prepubertal gynecomastia linked to lavender and tea tree oils. N Engl J Med 2007; 356:479.
  24. Gottswinter JM, Korth-Schütz S, Ziegler R. Gynecomastia caused by estrogen containing hair lotion. J Endocrinol Invest 1984; 7:383.
  25. DiRaimondo CV, Roach AC, Meador CK. Gynecomastia from exposure to vaginal estrogen cream. N Engl J Med 1980; 302:1089.
  26. Patisaul HB, Jefferson W. The pros and cons of phytoestrogens. Front Neuroendocrinol 2010; 31:400.
  27. Kolodny RC, Masters WH, Kolodner RM, Toro G. Depression of plasma testosterone levels after chronic intensive marihuana use. N Engl J Med 1974; 290:872.
  28. Harmon J, Aliapoulios MA. Gynecomastia in marihuana users. N Engl J Med 1972; 287:936.
  29. Harmon JW, Aliapoulios MA. Marijuana-induced gynecomastia: clinical and laboratory experience. Surg Forum 1974; 25:423.
  30. Narula HS, Carlson HE. Gynaecomastia--pathophysiology, diagnosis and treatment. Nat Rev Endocrinol 2014; 10:684.
  31. Hasle H, Mellemgaard A, Nielsen J, Hansen J. Cancer incidence in men with Klinefelter syndrome. Br J Cancer 1995; 71:416.
  32. Swerdlow AJ, Schoemaker MJ, Higgins CD, et al. Cancer incidence and mortality in men with Klinefelter syndrome: a cohort study. J Natl Cancer Inst 2005; 97:1204.
  33. Daniels IR, Layer GT. Testicular tumours presenting as gynaecomastia. Eur J Surg Oncol 2003; 29:437.
  34. Kolitsas N, Tsambalas S, Dimitriadis F, et al. Gynecomastia as a first clinical sign of nonseminomatous germ cell tumor. Urol Int 2011; 87:248.
  35. Harris M, Rizvi S, Hindmarsh J, Bryan R. Testicular tumour presenting as gynaecomastia. BMJ 2006; 332:837.
  36. Cuhaci N, Polat SB, Evranos B, et al. Gynecomastia: Clinical evaluation and management. Indian J Endocrinol Metab 2014; 18:150.
  37. Gordon DL, Brown JL, Emanuele NV, Hall L 3rd. Gynecomastia as the initial manifestation of hyperthyroidism. Endocr Pract 1997; 3:80.
  38. Binder G, Iliev DI, Dufke A, et al. Dominant transmission of prepubertal gynecomastia due to serum estrone excess: hormonal, biochemical, and genetic analysis in a large kindred. J Clin Endocrinol Metab 2005; 90:484.
  39. Shozu M, Sebastian S, Takayama K, et al. Estrogen excess associated with novel gain-of-function mutations affecting the aromatase gene. N Engl J Med 2003; 348:1855.
  40. Fukami M, Miyado M, Nagasaki K, et al. Aromatase excess syndrome: a rare autosomal dominant disorder leading to pre- or peri-pubertal onset gynecomastia. Pediatr Endocrinol Rev 2014; 11:298.
  41. Fukami M, Tsuchiya T, Vollbach H, et al. Genomic basis of aromatase excess syndrome: recombination- and replication-mediated rearrangements leading to CYP19A1 overexpression. J Clin Endocrinol Metab 2013; 98:E2013.
  42. Hellmann P, Christiansen P, Johannsen TH, et al. Male patients with partial androgen insensitivity syndrome: a longitudinal follow-up of growth, reproductive hormones and the development of gynaecomastia. Arch Dis Child 2012; 97:403.
  43. Bouwsma G, Van Wijngaarden GK. Spinal muscular atrophy and hypertrophy of the calves. J Neurol Sci 1980; 44:275.
  44. Sperfeld AD, Karitzky J, Brummer D, et al. X-linked bulbospinal neuronopathy: Kennedy disease. Arch Neurol 2002; 59:1921.
  45. Echaniz-Laguna A, Rousso E, Anheim M, et al. A family with early-onset and rapidly progressive X-linked spinal and bulbar muscular atrophy. Neurology 2005; 64:1458.
  46. Wasniewska M, Arrigo T, Lombardo F, et al. 11-Hydroxylase deficiency as a cause of pre-pubertal gynecomastia. J Endocrinol Invest 2009; 32:387.
  47. Zadik Z, Pertzelan A, Kaufman H, et al. Gynaecomastia in two prepubertal boys with congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency. Helv Paediatr Acta 1979; 34:185.
  48. Cavanah SF, Dons RF. Partial 3 beta-hydroxysteroid dehydrogenase deficiency presenting as new-onset gynecomastia in a eugonadal adult male. Metabolism 1993; 42:65.
  49. Wasniewska M, Raiola G, Galati MC, et al. Non-classical 21-hydroxylase deficiency in boys with prepubertal or pubertal gynecomastia. Eur J Pediatr 2008; 167:1083.
  50. Levine LS, DiGeorge AM. Adrenal disorders and genital abnormalities. In: Nelson Textbook of Pediatrics, 16th ed, Behman RE, Kliegman RM, Jenson HB (Eds), WB Saunders, Philadelphia 2000.
  51. Auchterlonie IA, Cameron J, Wallace AM, et al. Pre-pubertal gynaecomastia as the presenting feature of late-onset 21-hydroxylase deficiency. Horm Res 1985; 22:94.
  52. Blackett MD PR, Freeman MD DA. Androstenedione aromatization as a cause of gynecomastia in 11beta-hydroxylase and 21-hydroxylase deficiencies. Endocr Pract 1996; 2:90.
  53. Khadilkar KS, Budyal SR, Kasaliwal R, et al. OVOTESTICULAR DISORDER OF SEX DEVELOPMENT: A SINGLE-CENTER EXPERIENCE. Endocr Pract 2015; 21:770.
  54. Kaufman J, Messazos B, Sharples-Blissland N, Cameron F. Extreme physiological gynaecomastia in the neonate: Observation not intervention. J Paediatr Child Health 2015; 51:1030.
  55. Rajdev SK, Makwana N, Lester R, Agwu JC. An unusual case of bilateral galactocoele in a male infant. Arch Dis Child 2011; 96:1087.
  56. Fentiman IS, Fourquet A, Hortobagyi GN. Male breast cancer. Lancet 2006; 367:595.
  57. Misra M, Sagar P, Friedmann AM, et al. CASE RECORDS of the MASSACHUSETTS GENERAL HOSPITAL. Case 12-2016. An 8-Year-Old Boy with an Enlarging Mass in the Right Breast. N Engl J Med 2016; 374:1565.
  58. Giordano SH. A review of the diagnosis and management of male breast cancer. Oncologist 2005; 10:471.
  59. Anderson WF, Jatoi I, Tse J, Rosenberg PS. Male breast cancer: a population-based comparison with female breast cancer. J Clin Oncol 2010; 28:232.
  60. Brinton LA, Cook MB, McCormack V, et al. Anthropometric and hormonal risk factors for male breast cancer: male breast cancer pooling project results. J Natl Cancer Inst 2014; 106:djt465.
  61. Weiss JR, Moysich KB, Swede H. Epidemiology of male breast cancer. Cancer Epidemiol Biomarkers Prev 2005; 14:20.
  62. García CJ, Espinoza A, Dinamarca V, et al. Breast US in children and adolescents. Radiographics 2000; 20:1605.
  63. Giordano SH, Buzdar AU, Hortobagyi GN. Breast cancer in men. Ann Intern Med 2002; 137:678.
  64. Einav-Bachar R, Phillip M, Aurbach-Klipper Y, Lazar L. Prepubertal gynaecomastia: aetiology, course and outcome. Clin Endocrinol (Oxf) 2004; 61:55.
  65. Lemaine V, Cayci C, Simmons PS, Petty P. Gynecomastia in adolescent males. Semin Plast Surg 2013; 27:56.
  66. Ersek RA, Schaeferele M, Beckham PH, Salisbury MA. Gynecomastia: A clinical review. Aesthet Surg J 2000; 20:A1.
  67. Bowers SP, Pearlman NW, McIntyre RC Jr, et al. Cost-effective management of gynecomastia. Am J Surg 1998; 176:638.
  68. Lapid O, van Wingerden JJ, Perlemuter L. Tamoxifen therapy for the management of pubertal gynecomastia: a systematic review. J Pediatr Endocrinol Metab 2013; 26:803.
  69. Abaci A, Buyukgebiz A. Gynecomastia: review. Pediatr Endocrinol Rev 2007; 5:489.
  70. Handschin AE, Bietry D, Hüsler R, et al. Surgical management of gynecomastia--a 10-year analysis. World J Surg 2008; 32:38.